Dyronib 50 mg Tablet
$147,33
$68,61
Dyronib 50 mg Tablet is an effective anti-cancer medication that features dasatinib as its active ingredient, specifically designed to combat certain malignancies. This powerful treatment is primarily indicated for patients diagnosed with chronic myeloid leukemia (CML), a form of blood cancer that disrupts the normal production of white blood cells. By inhibiting specific enzymes that promote cancer cell growth, Dyronib helps to reduce the number of abnormal cells in the bloodstream, thereby improving overall health outcomes. Patients should be aware that this medication may cause side effects, including low blood cell counts and potential heart issues, making it essential to undergo regular monitoring during treatment. It is crucial to consult with a healthcare professional prior to starting Dyronib to ensure it is suitable for your specific condition and to discuss any potential drug interactions. With its targeted approach, Dyronib 50 mg Tablet represents a vital option for individuals seeking to manage their CML effectively. Always adhere to your doctor's instructions and report any unusual symptoms promptly to ensure optimal treatment efficacy and safety.
數量
Active Pharmaceutical Ingredient
Uses
• Dyronib 50 mg tablet is primarily used to treat chronic myeloid leukemia (CML), a cancer that impacts the blood and bone marrow. This medication helps manage the symptoms associated with CML, such as fatigue, weakness, and an enlarged spleen. By targeting the underlying disease process, Dyronib 50 mg tablet aims to improve the quality of life for patients. Regular monitoring and assessment are essential for evaluating its effectiveness in individual cases.
• In addition to CML, Dyronib 50 mg tablet is indicated for the treatment of acute lymphoblastic leukemia (ALL). This type of leukemia is characterized by the rapid proliferation of immature white blood cells. Dyronib 50 mg tablet helps to control the progression of ALL, addressing symptoms like fatigue and increased susceptibility to infections. Its role in therapy is crucial for managing this aggressive form of cancer and facilitating better patient outcomes.
• Dyronib 50 mg tablet is effective in targeting specific molecular pathways involved in leukemia, providing a tailored approach to treatment. By inhibiting certain proteins that drive cancer cell growth, this medication helps to slow down disease progression. Patients receiving Dyronib 50 mg tablet may experience a reduction in disease-related symptoms, contributing to an overall improvement in their health status. This targeted therapy represents an advancement in the management of leukemia.
• For patients diagnosed with CML or ALL, Dyronib 50 mg tablet serves as a vital component of their treatment regimen. The medication is often prescribed in conjunction with other therapies to enhance its effectiveness. Regular follow-ups are important to monitor the response to Dyronib 50 mg tablet and adjust treatment plans as needed. This collaborative approach helps ensure that patients receive comprehensive care tailored to their specific needs.
Benefits
Dyronib 50 mg Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Dyronib 50 mg Pack is usually taken once a day, which may be more convenient for some people compared to other treatments. Dyronib 50 mg is effective in people with CML or ALL who have not responded to other treatments.
Side Effects
Anti-cancer Drug Dyronib may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Fever
• Nausea
• Vomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
Common Side Effects
• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
How To Use
Dasatinib Tablet 50 mg may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Dyronib 50 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Dyronib 50 mg Tablet and report any unusual symptoms or changes in kidney function to their physician. The dose of Dyronib 50 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Dyronib 50 mg Pack. Dyronib 50 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Anti-cancer Drug Dyronib, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dyronib 50 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Dyronib 50 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Dasatinib Tablet 50 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Dyronib 50 mg may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-cancer Drug Dyronib during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Dyronib 50 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Dyronib Tablet.